Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Archive of Views

<< 2011 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2013 >>

14 August 2012: A Culture of Success Will be the Olympics' Greatest Legacy

By Stephen Caddick, Vice-Provost (Enterprise) at UCL
Britain's haul of gold medals in the Olympics has changed the nation's perceptions of our small island: we can emphatically be winners.
More...

7 August 2012: Going for broke: how universities can deliver on their economic potential

By Stephen Caddick, Vice-Provost (Enterprise) at UCL
The UK needs an economic game changer and we are incredibly fortunate to have a platform from which we can launch it – our universities.
More...

<< 2011 Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 2013 >>